China Biologic Products Holdings, Inc.

Industry

  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • CBPO Holdings Limited
  • CBPO Group Limited
  • Guiyang Dalin Biologic Technologies Co., Ltd.
  • Guizhou Taibang Biological Products Co. Ltd.
  • Shandong Taibang Biological Products Co., Ltd.
  • Tianxinfu Medical Appliance Co., Ltd.
See more in Biomedtracker

Latest on China Biologic Products Holdings, Inc.

Scrip

Lilly To Decide Next Steps After Formal FDA 'Nay' For First Chinese PD-1

 
• By Brian Yang

The US Food and Drug Administration has issued an official complete response letter to Eli Lilly and Company for the immuno-oncology agent, Tvvyt (sintilimab), developed by its partner Innovent Bio

Pink Sheet

Rare Chance Or Passing Opportunity: China Expands Orphan Drug Coverage With Steep Price Cuts

 
• By Brian Yang

Prepare yourself to learn about a drastic drug price reduction in China: CNY700,000 to CNY33,000. The drug in the spotlight is Biogen’s Spinraza (nusinersen), approved for a rare form of the severe ne

Scrip

Balancing Act: Orphan Drug Makers Slash Prices In China As New Mechanism Allures

 
• By Brian Yang

Prepare yourself to learn about a drastic drug price reduction in China: CNY700,000 to CNY33,000. The product in the spotlight is Biogen, Inc. ’s Spinraza (nusinersen), which is used for a rare form

Scrip

APAC Life Sciences Valuation Trends: Chinese Firms Eclipse Japan, India Peers

 
• By Anju Ghangurde

The top listed Chinese healthcare and life sciences companies have had a strong run on the stock market over the recent past, including during the COVID-19 outbreak, with price-to-earnings (PE) multip